EUCTR2020-001366-11-PT
Active, not recruiting
Phase 1
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care - Solidarity
AICIB0 sites100,000 target enrollmentMay 4, 2020
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- COVID-19
- Sponsor
- AICIB
- Enrollment
- 100000
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •consenting adults (age \=18\) hospitalised with definite COVID\-19, not already receiving any of the study drugs
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 500
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range 2000
Exclusion Criteria
- •known allergy or contra\-indications to investigational products
- •anticipated transfer within 72 hours to a non\-study hospital.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careEUCTR2020-001366-11-LVWorld Health Organization100,000
Active, not recruiting
Phase 1
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careCOVID-19Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-001366-11-IEWorld Health Organisation100,000
Active, not recruiting
Phase 1
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careCOVID-19Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2020-001366-11-ESFIB-HCSC100,000
Active, not recruiting
Phase 1
An international randomised trial of additional treatments for COVID-19 inhospitalised patients who are all receiving the local standard of careEUCTR2020-001366-11-ROMinistry of Health100,000
Active, not recruiting
Phase 1
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careEUCTR2020-001366-11-SKMinisterstvo Zdravotníctva Slovenskej republiky100,000